La Roche-Posay Awards 2025 Young Investigator Grants and Opens Applications for the Upcoming Year
La Roche-Posay, a premier name in dermatologist-recommended skincare, has proudly announced the winners of its prestigious Young Investigator Grant for 2025, marking a significant milestone in fostering innovative dermatological research. This program, now in its 20th year, has successfully provided essential funding aimed at early-career dermatologists, residents, and fellows. With a total of $50,000 in grants awarded this year, the funding highlights the organization's ongoing commitment to enhancing patient care through clinical biology, pharmacology, and medical research.
The 2025 grant recipients were officially celebrated at the recent American Academy of Dermatology (AAD) Annual Meeting held in Denver, Colorado. The prizes were administered by a distinguished panel of board-certified dermatologists, with Dr. Adam Friedman chairing the review committee. The eight selected winners were recognized not only for their innovative research proposals but also for their potential to significantly improve patient outcomes in the field of dermatology.
Among the notable grant recipients was Dr. Junqian Zhang, whose project focuses on the development and evaluation of a translucent suture pad designed to enhance suturing education in dermatologic surgery. Another groundbreaking study was presented by Dr. Leonardo Tjahjono, who conducted a prospective observational study on combined biologic therapy for active Hurley II/III hidradenitis suppurativa, an often challenging condition without biologic interruption.
Dr. Matthew Draelos is exploring cutting-edge techniques in non-melanoma skin cancer detection, utilizing topically applied chemical probes for visual fluorescence-based detection and surgical management of this widespread ailment. Meanwhile, Dr. Miguel Angel Aristizabal Torres is working on a transplant-specific quality-of-life module aimed at augmenting existing measures for solid organ transplant recipients afflicted with keratinocyte carcinoma.
Dr. Misty Eleryan addresses the urgent need for improved skin cancer detection in rural communities through a hybrid teledermatology and mobile care model. In an innovative approach, Dr. Rohan Shah’s project focuses on a trauma-informed dermatologic initiative that employs laser therapy to empower survivors of human trafficking. Other recipients include Dr. William Lewis, who is conducting research on fractional cryotherapy to enhance skin resurfacing and manage pigmentation.
La Roche-Posay has consistently demonstrated a strong commitment to nurturing the next generation of researchers who are pushing the frontiers of scientific knowledge in dermatology. Jessica Allison, the AVP of Medical Relations at La Roche-Posay, emphasized the value of the varied research projects, which range from advanced teledermatology applications to foundational studies addressing rare diseases. By sponsoring such pioneering research, La Roche-Posay plays a crucial role in advancing effective, accessible, and research-backed dermatological care tailored to diverse skin types.
For aspiring researchers, the window for applications for the 2026 Young Investigator Grant is now open. La Roche-Posay is inviting submissions that can receive funding of up to $50,000, aimed at promising projects from dermatology residents, fellows, and practitioners within their initial five years post-residency in the United States. The submission process entails a detailed research plan with a maximum of 8 pages, a comprehensive CV including contact details, a mentorship support letter, verification of no other funding, and a budget proposal.
Prospective applicants must ensure that their proposals are submitted by November 1, 2026, through the La Roche-Posay grant proposal portal. Winners will be announced in early 2027, with recognition expected at the AAD Meeting in San Francisco in March.
La Roche-Posay, trusted by over 100,000 dermatologists worldwide, remains dedicated to delivering transformative skincare solutions for various skin concerns, utilizing minerals from the Thermal Center in France. With a legacy spanning over 25 years and rigorous studies validating their products’ effectiveness, La Roche-Posay is committed to providing dermatological breakthroughs that cater to all skin types, including the most sensitive.
The 2025 grant recipients were officially celebrated at the recent American Academy of Dermatology (AAD) Annual Meeting held in Denver, Colorado. The prizes were administered by a distinguished panel of board-certified dermatologists, with Dr. Adam Friedman chairing the review committee. The eight selected winners were recognized not only for their innovative research proposals but also for their potential to significantly improve patient outcomes in the field of dermatology.
Among the notable grant recipients was Dr. Junqian Zhang, whose project focuses on the development and evaluation of a translucent suture pad designed to enhance suturing education in dermatologic surgery. Another groundbreaking study was presented by Dr. Leonardo Tjahjono, who conducted a prospective observational study on combined biologic therapy for active Hurley II/III hidradenitis suppurativa, an often challenging condition without biologic interruption.
Dr. Matthew Draelos is exploring cutting-edge techniques in non-melanoma skin cancer detection, utilizing topically applied chemical probes for visual fluorescence-based detection and surgical management of this widespread ailment. Meanwhile, Dr. Miguel Angel Aristizabal Torres is working on a transplant-specific quality-of-life module aimed at augmenting existing measures for solid organ transplant recipients afflicted with keratinocyte carcinoma.
Dr. Misty Eleryan addresses the urgent need for improved skin cancer detection in rural communities through a hybrid teledermatology and mobile care model. In an innovative approach, Dr. Rohan Shah’s project focuses on a trauma-informed dermatologic initiative that employs laser therapy to empower survivors of human trafficking. Other recipients include Dr. William Lewis, who is conducting research on fractional cryotherapy to enhance skin resurfacing and manage pigmentation.
La Roche-Posay has consistently demonstrated a strong commitment to nurturing the next generation of researchers who are pushing the frontiers of scientific knowledge in dermatology. Jessica Allison, the AVP of Medical Relations at La Roche-Posay, emphasized the value of the varied research projects, which range from advanced teledermatology applications to foundational studies addressing rare diseases. By sponsoring such pioneering research, La Roche-Posay plays a crucial role in advancing effective, accessible, and research-backed dermatological care tailored to diverse skin types.
For aspiring researchers, the window for applications for the 2026 Young Investigator Grant is now open. La Roche-Posay is inviting submissions that can receive funding of up to $50,000, aimed at promising projects from dermatology residents, fellows, and practitioners within their initial five years post-residency in the United States. The submission process entails a detailed research plan with a maximum of 8 pages, a comprehensive CV including contact details, a mentorship support letter, verification of no other funding, and a budget proposal.
Prospective applicants must ensure that their proposals are submitted by November 1, 2026, through the La Roche-Posay grant proposal portal. Winners will be announced in early 2027, with recognition expected at the AAD Meeting in San Francisco in March.
La Roche-Posay, trusted by over 100,000 dermatologists worldwide, remains dedicated to delivering transformative skincare solutions for various skin concerns, utilizing minerals from the Thermal Center in France. With a legacy spanning over 25 years and rigorous studies validating their products’ effectiveness, La Roche-Posay is committed to providing dermatological breakthroughs that cater to all skin types, including the most sensitive.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.